News Feed Search

Results for search query: 'research and development'

Page 1

Image of article 'L OREAL CO/ADR (OTCMKTS:LRLCY) Downgraded to “Hold” at Zacks Investment Research'

L OREAL CO/ADR (OTCMKTS:LRLCY) Downgraded to “Hold” at Zacks Investment Research

Get a free copy of the Zacks research report on L OREAL CO/ADR (LRLCY) For more information about research offerings from Zacks Investment Research, visit Zacks.com Receive News & Ratings for L OREAL CO/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for L OREAL CO/ADR and related companies with MarketBeat.com's FREE daily email newsletter.

Finally, Credit Suisse Group reissued an underperform rating on shares of L OREAL CO/ADR in a research report on Monday, August 3rd.

Royal Bank of Canada reissued a sector perform rating on shares of L OREAL CO/ADR in a research report on Monday, August 3rd.

Berenberg Bank reissued a sell rating on shares of L OREAL CO/ADR in a research report on Tuesday, August 4th.

Zacks Investment Research downgraded shares of L OREAL CO/ADR (OTCMKTS:LRLCY) from a buy rating to a hold rating in a research report sent to investors on Saturday morning, Zacks.com reports.

Why the Tesla (NASDAQ:TSLA) share price zoomed 12.5% higher

Following this gain, the Tesla share price is now up 388% since the start of the year.

Nevertheless, the trends are positive for Tesla app downloads, which appears to be an indication that its car sales and deliveries have been strong.

Goldman said: “Tesla global weekly app downloads have recently been tracking up on a year-over-year basis, with the most recent full week of global data up about 20% yoy.”

There were a couple of catalysts for Tesla’s strong share price gain on Monday night.

The Tesla Inc (NASDAQ: TSLA) share price was an exceptionally strong performer on Wall Street on Monday night.

Image of article 'This Collective of Companies is Revolutionizing the Beverage World'

This Collective of Companies is Revolutionizing the Beverage World

LOS ANGELES, Sept. 14, 2020 /PRNewswire/ -- Aseppak, a company dedicated to the development of functional food and beverages and Eybna, global leader in the research and development of natural terpenes, have developed a proprietary portfolio of functional flavors and active components specially designed for wellness beverages.

This partnership, born for the purpose of doing joint research and development projects, will be launching a premium line of functional flavors on September 2020 in Colorado and California.

Eybna has joined this collective of innovation-oriented companies that will continue to perform joint research and development projects for the consumer packaged goods (CPG) industry.

By establishing this partnership Aseppak and Eybna will be able to leverage clinical and market data to support every new formulation.

Eybna's recent finding on its NT-VRL formulation will be also integrated in this mutual portfolio, and the companies are now progressing on the development of functional beverages.

published agriculture economy

Societe Generale Reaffirms “Buy” Rating for LVMH Moet Hennessy Louis Vuitton (OTCMKTS:LVMUY

Finally, UBS Group reaffirmed a buy rating on shares of LVMH Moet Hennessy Louis Vuitton in a research note on Tuesday, July 28th.

Credit Suisse Group reaffirmed an outperform rating on shares of LVMH Moet Hennessy Louis Vuitton in a research note on Wednesday, July 29th.

Royal Bank of Canada reaffirmed an outperform rating on shares of LVMH Moet Hennessy Louis Vuitton in a research note on Wednesday, June 3rd.

Jefferies Financial Group upgraded LVMH Moet Hennessy Louis Vuitton from a hold rating to a buy rating in a research report on Monday, August 17th.

Receive News & Ratings for LVMH Moet Hennessy Louis Vuitton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LVMH Moet Hennessy Louis Vuitton and related companies with MarketBeat.com's FREE daily email newsletter.

published research and development business
Image of article 'COVID-19 made your data set worthless. Now what'

COVID-19 made your data set worthless. Now what

The COVID-19 pandemic has perplexed data scientists and creators of machine learning tools as the sudden and major change in consumer behavior has made predictions based on historical data nearly useless.

There is also very little point in trying to train new prediction models during the crisis, as one simply cannot predict chaos.

Thus, a model based purely on historical data will try to reproduce “what is normal” and is likely to give inaccurate predictions.

In the long run, though, this crisis reminded us that there are events so complex even we humans still struggle to understand, let alone predictive systems we have built to systematize our understanding in normal times.

How we enable AI systems to adapt as efficiently as we do – in terms of the number of data points – is very much an open question whose answer will define how much our technology will be able to be of help during the extremely volatile times that might be ahead of us.

published research and development technology
Image of article 'Defying the trend: No sign of slowdown for Fenner Dunlop'

Defying the trend: No sign of slowdown for Fenner Dunlop

Having spent heavily on technology improvements and research and development over the years, Abbott hints that Fenner Dunlop is also at the cusp of introducing new technology for conveyor system performance monitoring.

For the third press line, Fenner Dunlop has again partnered with German company Siempelkamp to develop a 18.5-metre long multi-piston press line, offering enhanced features to produce ply belts more efficiently, Abbott says.

The Kwinana plant is Fenner Dunlop’s 15th global conveyor belt manufacturing facility and its fourth steel cord plant.

After investing $70 million to build its steel cord plant at Kwinana in Western Australia in 2009, Fenner Dunlop spent another $20 million in 2013 to double the plant’s production capacity by installing a second press line.

The mining industry’s increasing demand for efficient conveyor belt solutions has driven conveyor belt manufacturer, Fenner Dunlop, to expand its Western Australia manufacturing facility to keep up.

Why BrainChip (ASX:BRN) and Recce (ASX:RCE) shares just hit record highs

In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can.

The Recce share price stormed to a record high of $1.88 yesterday.

Investors have been buying the artificial intelligence technology company’s shares after it announced a collaboration with VORAGO Technologies at the start of the month.

Here’s why they are on fire right now: The BrainChip share price rocketed to a record high of 78 cents on Tuesday.

Motley Fool Australia » Record Highs » Why BrainChip (ASX:BRN) and Recce (ASX:RCE) shares just hit record highs The Australian share market was on form on Tuesday and stormed notably higher again.

Image of article 'Qiagen readies launch of rapid portable coronavirus test (NYSE:QGEN'

Qiagen readies launch of rapid portable coronavirus test (NYSE:QGEN

Qiagen (NYSE:QGEN) announces plans to launch the Access Anti-SARS-CoV-2 Antigen Test designed to generate ~30 tests per hour from swab specimens using a small digital detection system.

The test, developed in collaboration with Australian digital diagnostics company Ellume, can generate a result in less than 15 minutes and is suited for high volume environments requiring fast accurate results.

Two versions of the Antigen Test, one for labs and one for point-of-care use, will be commercially available next quarter.

Feasibility tests showed sensitivity of at least 90% and specificity of 100%.

Image of article 'Orbit International (OTCMKTS:ORBT) Share Price Crosses Above 200 Day Moving Average of $4.66'

Orbit International (OTCMKTS:ORBT) Share Price Crosses Above 200 Day Moving Average of $4.66

Orbit International Corp. designs, manufactures, and sells electronic components and subsystems, and commercial and custom power units for prime contractors, government procurement agencies, and research and development laboratories in the United States and internationally.

Orbit International (OTCMKTS:ORBT) last released its earnings results on Tuesday, August 18th.

Orbit International shares last traded at $4.56, with a volume of 3,696 shares.

Orbit International Corp. (OTCMKTS:ORBT)’s stock price crossed above its two hundred day moving average during trading on Thursday .

See Also: How to Invest in an Index Fund Receive News & Ratings for Orbit International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orbit International and related companies with MarketBeat.com's FREE daily email newsletter.

published earnings business

Late-Night Binge-Watching Lowers Sperm Count, Study Finds

This study aimed to assess the relationship between evening exposure to the light-emitting screens of digital media devices and sperm quality," said Amit Green, Ph.D., head of research and development at the Sleep and Fatigue Institute at the Assuta Medical Center in Tel-Aviv, Israel, who led the study titled "Light Emitted from Media Devices at Night is Associated with Decline in Sperm Quality."

Preliminary results showed men who use light-emitting media devices in the evening and or right before bed experienced a more significant decline in sperm quality: "Smartphone and tablet use in the evening and after bedtime was correlated with a decline in sperm quality.

Furthermore, smartphone use in the evening, tablet use after bedtime, and television use in the evening were all correlated with the decline of sperm concentration," Green said.

"The results of this study revealed a link between evening and post-bedtime exposure to light-emitting digital media screens and sperm quality.

To the best of our knowledge, this is the first study to report these types of correlations between sperm quality and exposure time to SWL emitted from digital media, especially smartphones and tablets, in the evening and after bedtime," he said.

Image of article 'Alphabet's Verily begins offering stop-loss health insurance'

Alphabet's Verily begins offering stop-loss health insurance

Verily is bringing the hardware, software and data science to Coefficient, while Swiss Re has the distribution network and practical knowledge in the $20 billion stop-loss market.

Swiss Re made a minority investment in Coefficient, and the North American CEO of Swiss Re Corporate Solutions is poised to join the new company’s board of directors.

Verily is responsible for a suite of health gadgets, medical research and COVID-19 testing solutions, and it’s the company behind Project Baseline, a comprehensive four-year study into human health around the globe.

Once Coefficient Insurance finds its footing, Verily wants that smart watch and any other devices it builds to play a role in tracking employees’ health.

“Over time, Coefficient plans to integrate Verily’s suite of health devices and tech-driven interventions for workers and dependents into its precision risk solution to improve health outcomes and control cost,” a press release reads.

Image of article 'Qualigen picks up a bull who sees a two-bagger after release of COVID-19 test (NASDAQ:QLGN'

Qualigen picks up a bull who sees a two-bagger after release of COVID-19 test (NASDAQ:QLGN

In a note, analyst James Molloy regards the company as a "compelling opportunity" in cancer detection and treatment.

It currently markets its FastPack System for detecting prostate cancer, thyroid function and metabolic disorders.

It plans to launch the FastPack PRO SARS-CoV-2 IgG antibody test this quarter.

Lead therapeutic candidate is AS1411, a G-rich oligonucleotide that binds to a protein called nucleolin that is present on the surface of cancer cells.

Image of article 'Britishvolt appoints world-leading lithium-ion battery expert as Chief Technical Officer'

Britishvolt appoints world-leading lithium-ion battery expert as Chief Technical Officer

It is working with leading partners and suppliers to achieve this because it is of paramount importance to the future of the UK automotive industry and the overall economic and industrial health of the UK.

It is dedicated to supporting the future of electrified transportation and sustainable energy storage, producing world-leading lithium-ion battery technologies.

This strategy will be crucial for our automotive and energy industries and for the overall health of the UK economy."

Paterson, one of the world's leading specialists in automotive batteries and next-generation technologies, joins Britishvolt from The Faraday Institution where he was Head of Programme Management, spearheading research into lithium-ion batteries and garnering industry, academia and government resource to accelerate progress.

The company believes that the UK is the right place for its investments because of the strength of its automotive and energy industry, its expertise and history of industrial and academic battery research and development.

published energy and resource economy
Image of article 'A P MOLLER-MAER/ADR’s (AMKBY) Outperform Rating Reaffirmed at Credit Suisse Group'

A P MOLLER-MAER/ADR’s (AMKBY) Outperform Rating Reaffirmed at Credit Suisse Group

Finally, Barclays restated an underweight rating on shares of A P MOLLER-MAER/ADR in a research report on Thursday, July 2nd.

Zacks Investment Research cut shares of A P MOLLER-MAER/ADR from a buy rating to a hold rating in a research note on Wednesday, August 12th.

Berenberg Bank lowered shares of A P MOLLER-MAER/ADR from a hold rating to a sell rating in a research report on Thursday, May 28th.

Credit Suisse Group reissued their outperform rating on shares of A P MOLLER-MAER/ADR (OTCMKTS:AMKBY) in a research note issued to investors on Thursday, The Fly reports.

Further Reading: Moving Average – How it Helps Investors in Stock Selection Receive News & Ratings for A P MOLLER-MAER/ADR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for A P MOLLER-MAER/ADR and related companies with MarketBeat.com's FREE daily email newsletter.

published research and development business
Image of article 'TSMC 6nm process is currently in mass production'

TSMC 6nm process is currently in mass production

A few months ago, at the first-quarter earnings conference, TSMC CEO, Wei Zhejia, revealed that the 6nm process is in the risk trial production stage.

According to the company, TSMC’s 6nm process uses extreme ultraviolet lithography.

Information from TSMC’s official website shows that their 6nm process begun mass production on August 20.

According to a recent report, TSMC 6nm process is now in mass production.

According to a Nikkei Asian Review report, since last year, two Chinese companies have hired over 100 top engineers from TSMC to boost China’s chip manufacturing chances.

published research and development technology
Image of article 'Franco Nevada Corp (TSE:FNV) Director Catharine Elizabeth Goddard Farrow Sells 5,000 Shares'

Franco Nevada Corp (TSE:FNV) Director Catharine Elizabeth Goddard Farrow Sells 5,000 Shares

Eight Capital boosted their target price on shares of Franco Nevada from C$165.00 to C$200.00 in a research note on Monday, July 20th.

CIBC boosted their target price on shares of Franco Nevada from C$235.00 to C$245.00 in a research note on Thursday, August 6th.

CSFB set a C$105.00 target price on shares of Franco Nevada and gave the stock a “neutral” rating in a research note on Thursday, May 7th.

BMO Capital Markets boosted their target price on shares of Franco Nevada from C$184.00 to C$188.00 in a research note on Thursday, August 6th.

Finally, National Bank Financial boosted their target price on shares of Franco Nevada from C$215.00 to C$220.00 and gave the stock a “sector perform” rating in a research note on Wednesday, July 22nd.

published research and development business
Image of article 'Nutrien: Resilient Free Cash Flows And Improved Outlook Leave Room For Upside (NYSE:NTR'

Nutrien: Resilient Free Cash Flows And Improved Outlook Leave Room For Upside (NYSE:NTR

From a historical perspective, excluding a spike, NTR's average dividend yield is at 3.6% (Chart 3).

Not only NTR's cash flows were strong but also dividend payout remained comfortably within the target range.

In H2 2020, we expect NTR to realize higher prices for Retail, Nitrogen and the Phosphate segments.

Q2 2020 dividend payout ratio at 56% was higher than the previous quarters but well within NTR's management's stipulated target payout range of 40 to 60% of free cash flow.

During H1 2020, NTR's average per ton realized prices of Potash, Nitrogen and Phosphate were lower by 30%, 14% and 15% respectively.

Image of article 'Chinese tech firm actively recruiting AI talent in Singapore'

Chinese tech firm actively recruiting AI talent in Singapore

Black Sesame, which raised US$100 million (S$137 million) in its Series B financing round last year, is known for its visual perception solutions used for autonomous driving and advanced driver-assistance systems.

Speaking to The Straits Times in a video call, Mr Xu added that the focus will be on hiring Singaporeans and permanent residents for its research and development (R&D) centre here - the company's only one outside of the United States.

The artificial intelligence (AI) and automotive chip developer is actively recruiting AI talent and hopes to increase the number of employees from 20 now to 50 by the end of next year, said the firm's Singapore general manager Xu Jin.

While other firms have had to resort to mass layoffs amid the Covid-19 pandemic, Chinese tech company Black Sesame Technologies plans to more than double its headcount in Singapore within 11/2 years.

In June, the company released automotive chips that can support levels three and above of autonomous driving.

published chemicals technology
Image of article 'Increased hygiene practices boost Reckitt Benckiser H1'

Increased hygiene practices boost Reckitt Benckiser H1

Like-for-like sales for the three months ended June 30 rose 10.5%, beating company-provided estimates of 7.8%, but short of the 13.3% record growth in the first three months of the year.

Customers are also shopping more online, helping Reckitt's e-commerce sales surge more than 60% in the first half of the year, and now accounting about 12% the group's net revenue.

The Covid-19 pandemic has relieved pressure on a business that has struggled against intense competition in the health and hygiene sectors for several years.

Consumer goods maker Reckitt Benckiser today reported market beating first-half results, as households increasingly worried about health and hygiene stocked up on Lysol sprays, Dettol soap and Mucinex cough syrup.

Reckitt said it will invest £200m over the next two years in its baby formula business, boosting marketing for brands that have not benefited from Covid-related demand and hiring more people in research and development roles.

published marketing business

Moderna Gets Another $472M Federal Funding For Late-Stage Coronavirus Vaccine Development

Last week, Moderna suffered a setback in its vaccine development as it lost a bid to invalidate a key patent related to the technology for delivery of mRNA vaccines held by Arbutus Biopharma Corp (NASDAQ: ABUS).

Why It Matters Moderna claims it's on track to deliver nearly 500 million doses of the vaccine per year, and it could scale that number up to 1 billion doses next year due to its strategic collaboration with Lonza Group AG (OTC: LZAGY).

What Happened The Cambridge, Massachusetts-based company was originally allocated a $483 billion award, in support of its mRNA-1273 vaccine candidate, as part of its contract with the Biomedical Advanced Research and Development Authority (BARDA).

Moderna Inc. (NASDAQ: MRNA) announced Sunday it is receiving another $472 million funding from President Donald Trump's administration to support late-stage clinical development of its coronavirus vaccine candidate, including an expanded phase 3 study.

Earlier this month, it promised $1.6 billion in funding to Novavax, Inc (NASDAQ: NVAX) for its vaccine’s late-stage trial, reported Politico.

published chemicals finance
Image of article 'CENTRICA PLC/S (OTCMKTS:CPYYY) Upgraded by ValuEngine to “Hold'

CENTRICA PLC/S (OTCMKTS:CPYYY) Upgraded by ValuEngine to “Hold

Zacks Investment Research downgraded CENTRICA PLC/S from a hold rating to a sell rating in a research note on Monday, July 20th.

HSBC cut CENTRICA PLC/S from a buy rating to a hold rating in a research report on Monday, April 20th.

Royal Bank of Canada downgraded CENTRICA PLC/S from a sector perform rating to an underperform rating in a research report on Tuesday, April 7th.

ValuEngine upgraded shares of CENTRICA PLC/S (OTCMKTS:CPYYY) from a sell rating to a hold rating in a research note released on Thursday, ValuEngine reports.

Finally, Barclays upgraded CENTRICA PLC/S from an equal weight rating to an overweight rating in a research note on Tuesday, April 14th.

published research and development business
Image of article 'Zoom to open tech centre in India's Bengaluru'

Zoom to open tech centre in India's Bengaluru

Use of Zoom’s video conferencing services has surged at a time people across the world are working from home due to coronavirus curbs, but the company has also come under fire over privacy and security issues, spurring it to roll out major upgrades.

San Jose, California-based Zoom already has an office and a data centre in India’s financial capital Mumbai and a second data centre in Bengaluru.

Potential areas of expansion for the new technology centre include research and development, IT, security as well business operations, Velchamy Sankarlingam, Zoom’s president of product and engineering, told a virtual news conference.

REUTERS/Dado Ruvic/Illustration NEW DELHI (Reuters) - Zoom Video Communications Inc (ZM.O) said on Tuesday it will open a technology centre in the southern Indian city of Bengaluru and soon begin hiring as part of an expansion push in the country.

India has previously said Zoom is “not a safe platform”, joining other countries in expressing concern about the security of its services.

published telecommunication service technology

Solar + Battery in One Device Sets New Efficiency Standard

Ars Technica reports on an international team's demonstration of a device merging photovoltaic and battery hardware into a single, unified device "that can have extensive storage capacity... a device that's both stable and has efficiencies competitive with those of silicon panels .

"The article ends by suggesting this demonstration means researchers can now look for more stable battery and photovoltaic chemistries with improved efficiencies.

Image of article 'Invitation to Join Data Science Central'

Invitation to Join Data Science Central

Join the largest community of machine learning (ML), deep learning, AI, data science, business analytics, BI, operations research, mathematical and statistical professionals: Sign up here.

If instead, you are only interested in receiving our newsletter, you can subscribe here.

Our weekly digest features selected discussions, articles written by experts, forum questions and announcements aimed at machine learning, AI, IoT, analytics, data science, BI, operations research and big data practitioners.

It covers topics such as deep learning, AI, blockchain, visualization, automated machine learning, Hadoop, data integration and engineering, statistical science, computational statistics, analytics, pure data science, data security, and even computer-intensive methods in number theory.

It includes Click here to sign up and start receiving our newsletter.